概述
Astrocytoma is a type of brain tumor that originates from astrocytes, the star-shaped glial cells in the brain and spinal cord that support and nourish neurons. Astrocytomas are part of a broader category known as gliomas and are classified based on their grade (I to IV), which reflects how fast the tumor grows and how likely it is to spread.
- Grade I (Pilocytic Astrocytoma): Typically benign and slow-growing, often seen in children.
- Grade II (Diffuse Astrocytoma): Infiltrative, slow-growing but may progress.
- Grade III (Anaplastic Astrocytoma): Malignant, faster-growing.
- Grade IV (Glioblastoma): Most aggressive form.
症状
Symptoms vary depending on the tumor’s size and location in the brain but may include:
- Headaches (often worse in the morning)
- Seizures
- Nausea and vomiting
- Personality or behavior changes
- Weakness or numbness in parts of the body
- Difficulty with speech, vision, or coordination
病因与风险因素
The exact causes of astrocytoma are not fully understood, but factors may include:
- Genetic mutations (e.g., TP53, IDH1/IDH2)
- Family history of gliomas
- Radiation exposure (especially to the head during childhood)
- Age: Low-grade tumors are more common in younger individuals, while high-grade forms are more frequent in adults
诊断方法
Astrocytoma is diagnosed using:
- MRI scan with contrast: To visualize the tumor’s location and characteristics
- CT scan: Sometimes used for initial assessment
- Biopsy: To determine the grade and molecular profile
- Molecular testing: For IDH mutations, 1p/19q co-deletion, MGMT promoter methylation, and ATRX loss
治疗方案
Treatment depends on the tumor grade, size, location, and genetic characteristics:
- Surgery: Primary option for tumor removal
- Radiation therapy: Often used for intermediate to high-grade tumors
- Chemotherapy: Temozolomide is commonly used for Grade III and IV astrocytomas
- Targeted therapy and clinical trials: For selected molecular subtypes
- Observation: Sometimes recommended for asymptomatic low-grade tumors
预后情况
Prognosis varies significantly by tumor grade:
• Grade I (Pilocytic): Excellent prognosis; high long-term survival
• Grade II (Diffuse): May remain stable for years, but often progresses
• Grade III (Anaplastic): Median survival 2–5 years
• Grade IV (Glioblastoma): Median survival ~12–15 months
Prognosis improves with younger age, complete surgical resection, and favorable molecular markers (e.g., IDH mutation, MGMT methylation).
与此类癌症共处
Prognosis varies significantly by tumor grade:
- Grade I (Pilocytic): Excellent prognosis; high long-term survival
- Grade II (Diffuse): May remain stable for years, but often progresses
- Grade III (Anaplastic): Median survival 2–5 years
- Grade IV (Glioblastoma): Median survival ~12–15 months
Prognosis improves with younger age, complete surgical resection, and favorable molecular markers (e.g., IDH mutation, MGMT methylation).
预防与筛查
- No established screening protocol
- Minimize unnecessary radiation exposure, especially in children
- Genetic counseling for families with hereditary glioma syndromes (e.g., Li-Fraumeni)
FAQs
- Q: Is astrocytoma cancerous?
- A: Low-grade astrocytomas are considered benign or slow-growing. High-grade astrocytomas are malignant and aggressive.
- Q: Can astrocytomas come back after treatment?
- A: Yes, recurrence is common, especially in higher grades.
- Q: Can children get astrocytoma?
- A: Yes, particularly Grade I (pilocytic) astrocytomas are common in pediatric patients.
- Q: What’s the difference between astrocytoma and glioblastoma?
- A: Glioblastoma is a Grade IV astrocytoma — the most aggressive form.
相关资源
N/A
